Yifan Zheng

Yifan Zheng

Auto-generated profile, based on publicly available information

Yifan Zheng

Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YTYubo Tang
Yubo Tang
QWQingde Wa
Qingde Wa
LPLongyun Peng
Longyun Peng
YZYifan Zheng
Yifan Zheng
JCJie Chen
Jie Chen
SHShuai Huang
Shuai Huang
Mounting evidence demonstrates uncontrolled endoplasmic reticulum (ER) stress responses can activate the inflammasome, which generally results in endothelial dysfunction, a major pathogenetic factor of chronic inflammatory diseases such as atherosclerosis. Salvianolic acid B (SalB), produced by Radix Salviae, exerts antioxidative and anti‐inflammatory activities in multiple cell types. However, SalB’s effects on ER stress‐related inflammasome and endothelial dysfunction remain unknown. Here, we showed SalB substantially abrogated ER stress‐induced cell death and reduction in capillary tube formation, with declined intracellular reactive oxygen species (ROS) amounts and restored mitochondrial membrane potential (MMP), as well as increased expression of HO‐1 and SOD2 in bone marrow‐derived endothelial progenitor cells (BM‐EPCs). ER stress suppression by CHOP or caspase‐4 siRNA transfection attenuated the protective effect of SalB. Additionally, SalB alleviated ER stress‐mediated pyroptotic cell death via the suppression of TXNIP/NLRP3 inflammasome, as evidenced by reduced cleavage of caspase‐1 and interleukin‐ (IL‐) 1β and IL‐18 secretion levels. Furthermore, this study provided a mechanistic basis that AMPK/FoxO4/KLF2 and Syndecan‐4/Rac1/ATF2 signaling pathway modulation by SalB substantially prevented BM‐EPCs damage associated with ER stress by decreasing intracellular ROS amounts and inducing NLRP3‐dependent pyroptosis. In summary, our findings identify that ER stress triggered mitochondrial ROS release and NLRP3 generation in BM‐EPCs, while SalB inhibits NLRP3 inflammasome‐mediated pyroptotic cell death by regulating the AMPK/FoxO4/KLF2 and Syndecan‐4/Rac1/ATF2 pathways. The current findings reveal SalB as a potential new candidate for the treatment of atherosclerotic heart disease.

25 December 2023 in JMIR Formative Research
Verified
Journal Article
Open access
YZYifan Zheng
Yifan Zheng
BRBrigid Rowell
Brigid Rowell
QCQiyuan Chen
Qiyuan Chen
JKJin Yong Kim
Jin Yong Kim
RKRaed Al Kontar
Raed Al Kontar
CLCorey Lester
Corey Lester
Background: Medication errors, including dispensing errors, represent a substantial worldwide health risk with significant implications in terms of morbidity, mortality, and financial costs. Although pharmacists use methods like barcode scanning and double-checking for dispensing verification, these measures exhibit limitations. The application of artificial intelligence (AI) in pharmacy verification emerges as a potential solution, offering precision, rapid data analysis, and the ability to recognize medications through computer vision. For AI to be embraced, it must be designed with the end user in mind, fostering trust, clear communication, and seamless collaboration between AI and pharmacists. Objective: This study aimed to gather pharmacists’ feedback in a focus group setting to help inform the initial design of the user interface and iterative designs of the AI prototype. Methods: A multidisciplinary research team engaged pharmacists in a 3-stage process to develop a human-centered AI system for medication dispensing verification. To design the AI model, we used a Bayesian neural network that predicts the dispensed pills’ National Drug Code (NDC). Discussion scripts regarding how to design the system and feedback in focus groups were collected through audio recordings and professionally transcribed, followed by a content analysis guided by the Systems Engineering Initiative for Patient Safety and Human-Machine Teaming theoretical frameworks. Results: A total of 8 pharmacists participated in 3 rounds of focus groups to identify current challenges in medication dispensing verification, brainstorm solutions, and provide feedback on our AI prototype. Participants considered several teaming scenarios, generally favoring a hybrid teaming model where the AI assists in the verification process and a pharmacist intervenes based on medication risk level and the AI’s confidence level. Pharmacists highlighted the need for improving the interpretability of AI systems, such as adding stepwise checkmarks, probability scores, and details about drugs the AI model frequently confuses with the target drug. Pharmacists emphasized the need for simplicity and accessibility. They favored displaying only essential information to prevent overwhelming users with excessive data. Specific design features, such as juxtaposing pill images with their packaging for quick comparisons, were requested. Pharmacists preferred accept, reject, or unsure options. The final prototype interface included (1) checkmarks to compare pill characteristics between the AI-predicted NDC and the prescription’s expected NDC, (2) a histogram showing predicted probabilities for the AI-identified NDC, (3) an image of an AI-provided “confused” pill, and (4) an NDC match status (ie, match, unmatched, or unsure). Conclusions: In partnership with pharmacists, we developed a human-centered AI prototype designed to enhance AI interpretability and foster trust. This initiative emphasized human-machine collaboration and positioned AI as an augmentative tool rather than a replacement. This study highlights the process of designing a human-centered AI for dispensing verification, emphasizing its interpretability, confidence visualization, and collaborative human-machine teaming styles.

11 February 2025 in JMIR Human Factors
Verified
Journal Article
Open access
JKJin Yong Kim
Jin Yong Kim
VMVincent D Marshall
Vincent D Marshall
BRBrigid Rowell
Brigid Rowell
QCQiyuan Chen
Qiyuan Chen
YZYifan Zheng
Yifan Zheng
XYXi Jessie Yang
Xi Jessie Yang
Background: Dispensing errors significantly contribute to adverse drug events, resulting in substantial health care costs and patient harm. Automated pill verification technologies have been developed to aid pharmacists with medication dispensing. However, pharmacists’ trust in such automated technologies remains unexplored. Objective: This study aims to investigate pharmacists’ trust in automated pill verification technology designed to support medication dispensing. Methods: Thirty licensed pharmacists in the United States performed a web-based simulated pill verification task to determine whether an image of a filled medication bottle matched a known reference image. Participants completed a block of 100 verification trials without any help, and another block of 100 trials with the help of an imperfect artificial intelligence (AI) aid recommending acceptance or rejection of a filled medication bottle. The experiment used a mixed subjects design. The between-subjects factor was the AI aid type, with or without an AI uncertainty plot. The within-subjects factor was the four potential verification outcomes: (1) the AI rejects the incorrect drug, (2) the AI rejects the correct drug, (3) the AI approves the incorrect drug, and (4) the AI approves the correct drug. Participants’ trust in the AI system was measured. Mixed model (generalized linear models) tests were conducted with 2-tailed t tests to compare the means between the 2 AI aid types for each verification outcome. Results: Participants had an average trust propensity score of 72 (SD 18.08) out of 100, indicating a positive attitude toward trusting automated technologies. The introduction of an uncertainty plot to the AI aid significantly enhanced pharmacists’ end trust (t28=–1.854; P=.04). Trust dynamics were influenced by AI aid type and verification outcome. Specifically, pharmacists using the AI aid with the uncertainty plot had a significantly larger trust increment when the AI approved the correct drug (t78.98=3.93; P<.001) and a significantly larger trust decrement when the AI approved the incorrect drug (t2939.72=–4.78; P<.001). Intriguingly, the absence of the uncertainty plot led to an increase in trust when the AI correctly rejected an incorrect drug, whereas the presence of the plot resulted in a decrease in trust under the same circumstances (t509.77=–3.96; P<.001). A pronounced “negativity bias” was observed, where the degree of trust reduction when the AI made an error exceeded the trust gain when the AI made a correct decision (z=–11.30; P<.001). Conclusions: To the best of our knowledge, this study is the first attempt to examine pharmacists’ trust in automated pill verification technology. Our findings reveal that pharmacists have a favorable disposition toward trusting automation. Moreover, providing uncertainty information about the AI’s recommendation significantly boosts pharmacists’ trust in AI aid, highlighting the importance of developing transparent AI systems within health care.

25 May 2020 in BMJ Quality & Safety
Verified
Journal Article
Open access
PDF file
YZYifan Zheng
Yifan Zheng
YJYun Jiang
Yun Jiang
MDMichael P Dorsch
Michael P Dorsch
YDYuting Ding
Yuting Ding
VVV G Vinod Vydiswaran
V G Vinod Vydiswaran
CLCorey Lester
Corey Lester
Background Free-text directions generated by prescribers in electronic prescriptions can be difficult for patients to understand due to their variability, complexity and ambiguity. Pharmacy staff are responsible for transcribing these directions so that patients can take their medication as prescribed. However, little is known about the quality of these transcribed directions received by patients. Methods A retrospective observational analysis of 529 990 e-prescription directions processed at a mail-order pharmacy in the USA. We measured pharmacy staff editing of directions using string edit distance and execution time using the Keystroke-Level Model. Using the New Dale-Chall (NDC) readability formula, we calculated NDC cloze scores of the patient directions before and after transcription. We also evaluated the quality of directions (eg, included a dose, dose unit, frequency of administration) before and after transcription with a random sample of 966 patient directions. Results Pharmacy staff edited 83.8% of all e-prescription directions received with a median edit distance of 18 per e-prescription. We estimated a median of 6.64 s of transcribing each e-prescription. The median NDC score increased by 68.6% after transcription (26.12 vs 44.03, p<0.001), which indicated a significant readability improvement. In our sample, 51.4% of patient directions on e-prescriptions contained at least one pre-defined direction quality issue. Pharmacy staff corrected 79.5% of the quality issues. Conclusion Pharmacy staff put significant effort into transcribing e-prescription directions. Manual transcription removed the majority of quality issues; however, pharmacy staff still miss or introduce following their manual transcription processes. The development of tools and techniques such as a comprehensive set of structured direction components or machine learning–based natural language processing techniques may help produce clear directions.

18 April 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
CLCorey Lester
Corey Lester
BRBrigid Rowell
Brigid Rowell
YZYifan Zheng
Yifan Zheng
ZCZoe Co
Zoe Co
VMVincent Marshall
Vincent Marshall
XYX Jessie Yang
X Jessie Yang
Background: Artificial intelligence (AI)–based clinical decision support systems are increasingly used in health care. Uncertainty-aware AI presents the model’s confidence in its decision alongside its prediction, whereas black-box AI only provides a prediction. Little is known about how this type of AI affects health care providers’ work performance and reaction time. Objective: This study aimed to determine the effects of black-box and uncertainty-aware AI advice on pharmacist decision-making and reaction time. Methods: Recruitment emails were sent to pharmacists through professional listservs describing a web-based, crossover, randomized controlled trial. Participants were randomized to the black-box AI or uncertainty-aware AI condition in a 1:1 manner. Participants completed 100 mock verification tasks with AI help and 100 without AI help. The order of no help and AI help was randomized. Participants were exposed to correct and incorrect prescription fills, where the correct decision was to “accept” or “reject,” respectively. AI help provided correct (79%) or incorrect (21%) advice. Reaction times, participant decisions, AI advice, and AI help type were recorded for each verification. Likelihood ratio tests compared means across the three categories of AI type for each level of AI correctness. Results: A total of 30 participants provided complete datasets. An equal number of participants were in each AI condition. Participants’ decision-making performance and reaction times differed across the 3 conditions. Accurate AI recommendations resulted in the rejection of the incorrect drug 96.1% and 91.8% of the time for uncertainty-aware AI and black-box AI respectively, compared with 81.2% without AI help. Correctly dispensed medications were accepted at rates of 99.2% with black-box help, 94.1% with uncertainty-aware AI help, and 94.6% without AI help. Uncertainty-aware AI protected against bad AI advice to approve an incorrectly filled medication compared with black-box AI (83.3% vs 76.7%). When the AI recommended rejecting a correctly filled medication, pharmacists without AI help had a higher rate of correctly accepting the medication (94.6%) compared with uncertainty-aware AI help (86.2%) and black-box AI help (81.2%). Uncertainty-aware AI resulted in shorter reaction times than black-box AI and no AI help except in the scenario where “AI rejects the correct drug.” Black-box AI did not lead to reduced reaction times compared with pharmacists acting alone. Conclusions: Pharmacists’ performance and reaction times varied by AI type and AI accuracy. Overall, uncertainty-aware AI resulted in faster decision-making and acted as a safeguard against bad AI advice to approve a misfilled medication. Conversely, black-box AI had the longest reaction times, and user performance degraded in the presence of bad AI advice. However, uncertainty-aware AI could result in unnecessary double-checks, but it is preferred over false negative advice, where patients receive the wrong medication. These results highlight the importance of well-designed AI that addresses users’ needs, enhances performance, and avoids overreliance on AI.